Skip to main content

Advertisement

Log in

Office capillaroscopy in systemic sclerosis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The aims of this study are to assess the reliability of two office techniques, the ophthalmoscope and the Dermlite® dermatoscope, and to detect nailfold capillaroscopy abnormalities in systemic sclerosis (SSc). Two separate studies were performed. In the first, the nailfolds of two fingers on one hand of 13 SSc patients and two normals were examined by four rheumatologists using an ophthalmoscope. In the second, the nailfolds of the two fingers of each hand of six SSc patients and two normals were examined by six rheumatologists with a Dermlite® dermatoscope. Widefield capillary microscopy was performed by one observer in the ophthalmoscope study to assess validity. The examiners determined the presence or absence of dilated loops, giant capillary loops, and/or avascular areas on each digit. The kappa coefficient was calculated to demonstrate agreement. With the ophtalmoscope, the inter-observer kappa coefficients were 0.43, 0.54, and 0.19; the average intra-observer agreements were 0.61, 0.56, and 0.31; and the ophthalmoscope–microscope agreement were 0.63, 0.52, and <0.1 for dilated capillaries, giant capillaries, and avascular areas, respectively. With the dermatoscope, the kappa values for inter-observer reliability were 0.63, 0.40, and 0.20; and intra-observer reliability was 0.71, 0.55, and 0.40 for dilated capillaries, giant capillaries, and avascular areas, respectively. The ophthalmoscope and the dermatoscope provide moderate to substantial reliability to detect the presence of giant and dilated capillaries but poor inter-observer agreement for avascular areas. The ophthalmoscope is valid when compared to the microscope for detecting giant or dilated capillaries. We conclude that these techniques are useful office tools to detect capillary abnormalities in SSc.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Maricq HR, LeRoy EC (1973) Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 16:619–628

    Article  PubMed  CAS  Google Scholar 

  2. Maricq HR, Spencer-Green G, Leroy EC (1975) Abnormal capillary patterns and systemic disease in scleroderma (progressive systemic sclerosis). Bibl Anat 13:248–249

    PubMed  CAS  Google Scholar 

  3. Maricq HR, Spencer-Green G, LeRoy EC (1976) Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud’s syndrome and dermatomyositis. Am J Med 61:862–870

    Article  PubMed  CAS  Google Scholar 

  4. Maricq HR (1978) In vivo capillary microscopy for the clinician. Arthritis Rheum 21:173

    Article  PubMed  CAS  Google Scholar 

  5. Maricq HR (1981) Wide-field capillary microscopy. Arthritis Rheum 24:1159–1165

    Article  PubMed  CAS  Google Scholar 

  6. Cutolo M, Sulli A, Pizzorni C et al (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160

    PubMed  CAS  Google Scholar 

  7. Lonzetti LS, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44:735–736

    Article  PubMed  CAS  Google Scholar 

  8. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581–590

    Article  Google Scholar 

  9. Herd JK (1976) Nailfold capillary microscopy made easy. Arthritis Rheum 19:1370–1371

    Article  PubMed  CAS  Google Scholar 

  10. Anders HJ, Sigl T, Schattenkirchner M (2001) Differentiation between primary and secondary Raynaud’s phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope. Ann Rheum Dis 60:407–409

    Article  PubMed  CAS  Google Scholar 

  11. Minkin W, Rabhan NB (1982) Office nail fold capillary microscopy using ophthalmoscope. J Am Acad Dermatol 7:190–193

    PubMed  CAS  Google Scholar 

  12. Ranft J, Lammersen T, Heidrich H (1987) In vivo capillary microscopy findings and ophthalmoscopy findings in scleroderma. Arthritis Rheum 30:1173–1175

    Article  PubMed  CAS  Google Scholar 

  13. Bauersachs RM (1997) The poor man’s capillary microscope. A novel technique for the assessment of capillary morphology. Ann Rheum Dis 56:435–437

    PubMed  CAS  Google Scholar 

  14. Bergman R, Sharony L, Schapira D et al (2003) The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol 139:1027–1030

    Article  PubMed  Google Scholar 

  15. Chen ZY, Silver RM, Ainsworth SK et al (1984) Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 77:812–822

    Article  PubMed  CAS  Google Scholar 

  16. Maricq HR (1992) Capillary abnormalities, Raynaud’s phenomenon, and systemic sclerosis in patients with localized scleroderma. Arch Dermatol 128:630–632

    Article  PubMed  CAS  Google Scholar 

  17. Carpentier PH, Maricq HR (1990) Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 16:75–91

    PubMed  CAS  Google Scholar 

  18. Maricq HR, Harper FE, Khan MM et al (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1:195–205

    PubMed  CAS  Google Scholar 

  19. Maricq HR, Maize JC (1982) Nailfold capillary abnormalities. Clin Rheum Dis 8:455–478

    PubMed  CAS  Google Scholar 

  20. Maricq HR, Weinberger AB, LeRoy EC (1982) Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud’s phenomenon. J Rheumatol 9:289–291

    PubMed  CAS  Google Scholar 

  21. Kenik JG, Maricq HR, Bole GG (1981) Blind evaluation of the diagnostic specificity of nailfold capillary microscopy in the connective tissue diseases. Arthritis Rheum 24:885–891

    Article  PubMed  CAS  Google Scholar 

  22. Maricq HR, LeRoy EC, D’Angelo WA et al (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23:183–189

    Article  PubMed  CAS  Google Scholar 

  23. Maricq HR (1977) Variations in the skin microvascular patterns of the hand. Bibl Anat 16:164–169

    PubMed  Google Scholar 

  24. Arpaia G, Cimminiello C, Milani M et al (1989) A new capillaroscopic assessment of microvascular damage vs Maricq classification in patients with isolated Raynaud phenomenon. Int Angiol 8:129–133

    PubMed  CAS  Google Scholar 

  25. Maricq HR (1970) “Wide-field” photography of nailfold capillary bed and a scale of plexus visualization scores (PVS). Microvasc Res 2:335–340

    Article  PubMed  CAS  Google Scholar 

  26. Conger AJ (1980) Integration and generalisation of kappas for multiple raters. Psychol Bull 88:322–328

    Article  Google Scholar 

  27. Portney L, Watkins M (2000) Foundations of clinical research: applications to practice. Prenrice-Hall, New Jersey, pp 568–570

    Google Scholar 

  28. Walter SD, Eliasziw M, Donner A (1998) Sample size and optimal designs for reliability studies. Stat Med 17:101–110

    Article  PubMed  CAS  Google Scholar 

  29. Maricq HR (1966) Capillary morphology and the course of illness in schizophrenic patients. J of Nerv Ment Dis 142:63–71

    Article  CAS  Google Scholar 

  30. Wildt M, Hesselstrand R, Scheja A et al (1999) Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer-based analysis. Clin Exp Rheumatol 17:219–222

    PubMed  CAS  Google Scholar 

  31. Lee P, Leung FY, Alderdice C et al (1983) Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 10:930–938

    PubMed  CAS  Google Scholar 

  32. Tooth LR, Ottenbacher KJ (2004) The kappa statistic in rehabilitation research: an examination. Arch Phys Med Rehabil 85:1371–1376

    Article  PubMed  Google Scholar 

  33. Hoehler FK (2000) Bias and prevalence effects on kappa viewed in terms of sensitivity and specificity. J Clin Epidemiol 53:499–503

    Article  PubMed  CAS  Google Scholar 

Download references

Disclaimer

None of the authors has any financial interest in the manufacturing or sales of the dermatoscope used in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Murray Baron.

Additional information

For the Canadian Scleroderma Research Group

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baron, M., Bell, M., Bookman, A. et al. Office capillaroscopy in systemic sclerosis. Clin Rheumatol 26, 1268–1274 (2007). https://doi.org/10.1007/s10067-006-0489-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0489-6

Keywords

Navigation